A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions within just a few months, causing severe respiratory disease and mortality. Assays to monitor SARS-CoV-2 growth in vitro depend on time-consuming and costly RNA extraction steps, hampering progress in basic research and drug development efforts.
Here, we developed a simplified quantitative real-time PCR assay that bypasses viral RNA extraction steps and can monitor SARS-CoV-2 growth from a small amount of cell culture supernatants. In addition, we show that this approach is easily adaptable to numerous other RNA and DNA viruses. Using this assay, we screened the activities of a number of compounds that were predicted to alter SARS-CoV-2 entry and replication as well as HIV-1-specific drugs in a proof-of-concept study. We found that E64D (inhibitor of endosomal proteases cathepsin B and L) and apilimod (endosomal trafficking inhibitor) potently decreased the amount of SARS-CoV-2 RNA in cell culture supernatants with minimal cytotoxicity.
Surprisingly, we found that the macropinocytosis inhibitor ethylisopropylamiloride (EIPA) similarly decreased SARS-CoV-2 RNA levels in supernatants, suggesting that entry may additionally be mediated by an alternative pathway. HIV-1-specific inhibitors nevirapine (a nonnucleoside reverse transcriptase inhibitor [NNRTI]), amprenavir (a protease inhibitor), and allosteric integrase inhibitor 2 (ALLINI-2) modestly inhibited SARS-CoV-2 replication, albeit the 50% inhibitory concentration (IC50) values were much higher than that required for HIV-1. Taking the data together, this simplified assay will expedite basic SARS-CoV-2 research, be amenable to mid-throughput screening assays (i.e., drug, CRISPR, small interfering RNA [siRNA], etc.), and be applicable to a broad number of RNA and DNA viruses.
IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, is continuing to cause immense respiratory disease and social and economic disruptions. Conventional assays that monitor SARS-CoV-2 growth in cell culture rely on costly and time-consuming RNA extraction procedures, hampering progress in basic SARS-CoV-2 research and development of effective therapeutics.
Here, we developed a simple quantitative real-time PCR assay to monitor SARS-CoV-2 growth in cell culture supernatants that does not necessitate RNA extraction and that is as accurate and sensitive as existing methods. In a proof-of-concept screen, we found that E64D, apilimod, EIPA, and remdesivir can substantially impede SARS-Cov-2 replication, providing novel insight into viral entry and replication mechanisms.
In addition, we show that this approach is easily adaptable to numerous other RNA and DNA viruses. This simplified assay will undoubtedly expedite basic SARS-CoV-2 and virology research and be amenable to use in drug screening platforms to identify therapeutics against SARS-CoV-2.
rHu MIP-1-alpha |
|||
AK8250-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-1-alpha |
|||
AK8250-1000 | Akron Biotech | 1mg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-0005 | Akron Biotech | 5µg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-0020 | Akron Biotech | 20µg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-3-beta |
|||
AK8232-1000 | Akron Biotech | 1mg | Ask for price |
rHu MIP-4 |
|||
AK8218-0002 | Akron Biotech | 2µg | Ask for price |
rHu MIP-4 |
|||
AK8218-0010 | Akron Biotech | 10µg | Ask for price |
rHu MIP-4 |
|||
AK8218-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-4 |
|||
AK8218-1000 | Akron Biotech | 1mg | Ask for price |
Recombinant Human MIP-3/CCL23 (rHu MIP-3/CCL23) |
|||
JOT-PR1097 | Jotbody | 5µg | EUR 205 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T cell population using a concentration range of 10.0 -50.0 ng/ml, corresponding to a Specific Activity of >2 x 104 IU/mg. |
Recombinant Human MIP-3/CCL23 (rHu MIP-3/CCL23) |
|||
PR1097 | Bioworld Biotech | 5µg | EUR 158 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T cell population using a concentration range of 10.0 -50.0 ng/ml, corresponding to a Specific Activity of >2 x 104 IU/mg. |
rHu MIP-1-beta |
|||
AK8264-0002 | Akron Biotech | 2µg | Ask for price |
rHu MIP-1-beta |
|||
AK8264-0010 | Akron Biotech | 10µg | Ask for price |
rHu MIP-1-beta |
|||
AK8264-0100 | Akron Biotech | 100µg | Ask for price |
rHu MIP-1-beta |
|||
AK8264-1000 | Akron Biotech | 1mg | Ask for price |
Recombinant Human MIP-3 alpha (rHuMIP-3a/CCL20) |
|||
JOT-PR1096 | Jotbody | 5µg | EUR 205 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T lymphocytes using a concentration range of 10.0 -50.0 ng/ml, corresponding to a Specific Activity of >2 x 104 IU/mg. |
Recombinant Human MIP-3 alpha (rHuMIP-3a/CCL20) |
|||
PR1096 | Bioworld Biotech | 5µg | EUR 158 |
Description: Fully biologically active when compared to standard. Determined by its ability to chemoattract human T lymphocytes using a concentration range of 10.0 -50.0 ng/ml, corresponding to a Specific Activity of >2 x 104 IU/mg. |
MIP-3 ALPHA |
|||
GWB-70396B | GenWay Biotech | 0.02 mg | Ask for price |
MIP-3 Alpha Antibody |
|||
GWB-65BCF6 | GenWay Biotech | 0.1 mg | Ask for price |
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
JOT-PR1095 | Jotbody | 2µg | EUR 205 |
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
Recombinant Human MIP-1 beta (rHu MIP-1 beta /CCL4 |
|||
PR1095 | Bioworld Biotech | 2µg | EUR 158 |
Description: Determined by its ability to chemoattract human blood monocytes using a concentration range of 5.0-20.0 ng/ml, corresponding to a Specific Activity of >5 x 104 IU/mg. |
Monoclonal anti-human Alpha (FSH-Alpha), IgG clone 3 aff pure |
|||
FSHA12-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Rabbit Anti-Human Alpha Defensin 1-3 (NP1-3/hNP1-3)antiserum #1 |
|||
HDEFA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Human Alpha Defensin 1-3 (NP1-3/hNP1-3)control/blocking peptide #1 |
|||
HDEFA11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Human MIP-3 alpha (CCL20) |
|||
MBS691737-0005mg | MyBiosource | 0.005mg | EUR 300 |
Human MIP-3 alpha (CCL20) |
|||
MBS691737-002mg | MyBiosource | 0.02mg | EUR 450 |
Human MIP-3 alpha (CCL20) |
|||
MBS691737-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
Mouse MIP-3 alpha (CCL20) |
|||
MBS692015-0005mg | MyBiosource | 0.005mg | EUR 300 |
Mouse MIP-3 alpha (CCL20) |
|||
MBS692015-002mg | MyBiosource | 0.02mg | EUR 450 |
Mouse MIP-3 alpha (CCL20) |
|||
MBS692015-5x002mg | MyBiosource | 5x0.02mg | EUR 1725 |
MIP-3 alpha, CCL20, human |
|||
RC315-31 | Bio Basic | 5ug | EUR 125.26 |
Recombinant (E.Coli) Human p38 alpha/SAPK2 alpha |
|||
RP-675 | Alpha Diagnostics | 1 ug | EUR 343.2 |
Anti-Human MIP-3&alpha |
|||
GWB-BIG752 | GenWay Biotech | 500ug | Ask for price |
Rabbit Anti-Human Alpha Defensin 1-3 (NP1-3/hNP1-3), IgG #1, aff pure |
|||
HDEFA11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Murinoglobulin (alpha 1-inhibitor 3) Rat, purified protein |
|||
MGBN11-N-25 | Alpha Diagnostics | 25 ug | EUR 270 |
MIP-3 alpha Recombinant Protein |
|||
40-353-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and signals through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant murine MIP-3 alpha is a 7.9 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 alpha Recombinant Protein |
|||
40-353-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and signals through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant murine MIP-3 alpha is a 7.9 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 alpha Recombinant Protein |
|||
40-380-0005mg | ProSci | 0.005 mg | EUR 311.1 |
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and can signal through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 alpha is an 8.0 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 alpha Recombinant Protein |
|||
40-380-002mg | ProSci | 0.02 mg | EUR 437.1 |
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and can signal through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 alpha is an 8.0 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
MIP-3 alpha Polyclonal Antibody |
|||
BT-AP06995-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
Description: This antimicrobial gene belongs to the subfamily of small cytokine CC genes. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The protein encoded by this gene displays chemotactic activity for lymphocytes and can repress proliferation of myeloid progenitors. Two transcript variants encoding different isoforms have been found for this gene. |
MIP-3 alpha Polyclonal Antibody |
|||
BT-AP06995-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
Description: This antimicrobial gene belongs to the subfamily of small cytokine CC genes. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The protein encoded by this gene displays chemotactic activity for lymphocytes and can repress proliferation of myeloid progenitors. Two transcript variants encoding different isoforms have been found for this gene. |
MIP-3 alpha Polyclonal Antibody |
|||
BT-AP06995-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
Description: This antimicrobial gene belongs to the subfamily of small cytokine CC genes. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The protein encoded by this gene displays chemotactic activity for lymphocytes and can repress proliferation of myeloid progenitors. Two transcript variants encoding different isoforms have been found for this gene. |
MIP-3 alpha Polyclonal Antibody |
|||
JOT-AP06995-100ul | Jotbody | 100ul | EUR 220 |
MIP-3 alpha Polyclonal Antibody |
|||
JOT-AP06995-50ul | Jotbody | 50ul | EUR 144 |
Recombinant (E.Coli) Human GRO-beta/MIP-2 (CXCL2) |
|||
RP-1013 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant Mouse (E.Coli) GRO-beta/MIP-2 (CXCL2) |
|||
RP-1040 | Alpha Diagnostics | 5 ug | EUR 196.8 |
human Topoisomerase II alpha (TOP2 alpha) Control/blocking peptide |
|||
TOP2A11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Recombinant (Sf90) bovine Phosphoinositide 3-kinase alpha p110a/p85a |
|||
RP-733 | Alpha Diagnostics | 1 ug | EUR 343.2 |
Monoclonal anti-bovine GABAa Receptor alpha 1 (1-269aa) IgG #3, aff pure |
|||
GAA13-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Recombinant purified, human Interleukin-1 alpha (IL-1 alpha), active |
|||
IL1A15-R-10 | Alpha Diagnostics | 10 ug | EUR 416.4 |
MIP-1 ALPHA |
|||
GWB-2915BC | GenWay Biotech | 0.02 mg | Ask for price |
MIP-1 ALPHA |
|||
GWB-4CEC3A | GenWay Biotech | 0.02 mg | Ask for price |
MIP-1 ALPHA |
|||
GWB-C911A5 | GenWay Biotech | 0.01 mg | Ask for price |
Rabbit Anti-human Topoisomerase II alpha (TOP2 alpha) IgG, aff pure |
|||
TOP2A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rat MIP-3 alpha ELISA Kit |
|||
K0332170 | KOMA BIOTECH | 96well | EUR 271 |
Human/Rat GABAa Receptor alpha 3 (GAA3) Control/blocking peptide #1 |
|||
GAA31-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Mouse MIP-3 alpha ELISA Kit |
|||
K0332171 | KOMA BIOTECH | 96well | EUR 271 |
Human Core-binding factor alpha 3 (CBFA3) Control/blocking peptide # 1 |
|||
CBFA31-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
RABBIT ANTI HUMAN MIP-3 ALPHA |
|||
MBS221726-01mg | MyBiosource | 0.1mg | EUR 635 |
RABBIT ANTI HUMAN MIP-3 ALPHA |
|||
MBS221726-5x01mg | MyBiosource | 5x0.1mg | EUR 2695 |
Rabbit Anti-Human/Rat GABAa Receptor alpha 3 (GAA3) IgG, aff pure |
|||
GAA31-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Endothelial intergerin Alpha-V Beta-3 (Clone 17.16), RNA Aptamer, unlabeled |
|||
AR-287-U | Alpha Diagnostics | Custom | Ask for price |
Mouse Anti-Human MIP-3 alpha |
|||
MBS690971-05mg | MyBiosource | 0.5mg | EUR 525 |
Mouse Anti-Human MIP-3 alpha |
|||
MBS690971-5x05mg | MyBiosource | 5x0.5mg | EUR 2080 |
Anti-Human MIP-3 alpha Antibody |
|||
101-M79 | ReliaTech | 500 µg | EUR 246.75 |
Description: MIP-3α is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and can signal through the CCR6 receptor. MIP-3α is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Human MIP-3α is an 8.0 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Anti-Human MIP-3 alpha Antibody |
|||
102-P67 | ReliaTech | 100 µg | EUR 245.7 |
Description: MIP-3α is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and can signal through the CCR6 receptor. MIP-3α is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3α is an 8.0 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines. |
Murinoglobulin (alpha 1-inhibitor 3) Rat, purified protein control for western |
|||
MGBN11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Rabbit Anti-Rat Murinoglobulin (alpha 1-inhibitor 3) Rat, IgG, aff pure |
|||
MGBN11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Recombinant Human MIP-3 alpha (CCL20) |
|||
HECCP-2001 | Cyagen | 5ug | Ask for price |
Human MIP-3 alpha (CCL20) Recombinant |
|||
MBS553195-0005mg | MyBiosource | 0.005mg | EUR 165 |
Human MIP-3 alpha (CCL20) Recombinant |
|||
MBS553195-0025mg | MyBiosource | 0.025mg | EUR 245 |
Recombinant Human MIP-3 alpha (CCL20) |
|||
MBS4159697-0025mg | MyBiosource | 0.025mg | EUR 385 |
Recombinant Human MIP-3 alpha (CCL20) |
|||
MBS4159697-1mg | MyBiosource | 1(mg) | EUR 4600 |
Recombinant Human MIP-3 alpha (CCL20) |
|||
MBS4159697-5x1mg | MyBiosource | 5x1mg | EUR 20445 |
Recombinant Human MIP-3 alpha/CCL20 |
|||
P1220-.005 | ApexBio | 5ug | EUR 108.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human MIP-3 alpha/CCL20 |
|||
P1220-.1 | ApexBio | 100ug | EUR 900.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human MIP-3 alpha/CCL20 |
|||
P1220-.5 | ApexBio | 500ug | EUR 2020.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human MIP-3 alpha (CCL20) |
|||
Z100705 | ABM | 25 µg | EUR 235 |
Description: Macrophage inflammatory protein (MIP)-3/CCL20, also known as liver and activation-regulated chemokine (LARC) or Exodus, is a member of the CC chemokine subfamily initially noted to be expressed in human liver, lung, appendix, and tonsillar crypts. MIP-3 is selectively chemotactic for CD34(+) bone marrow cell-derived immature DCs and CD45RO(+) memory T cells that express the cognate receptor CCR6. MIP-3 produced at sites of inflammation may chemoattract CCR6-expressing immature DCs to the subepithelial region of mucosal surfaces. |
Recombinant Human MIP-3 alpha (CCL20) |
|||
Z100709 | ABM | 1.0 mg | EUR 3900 |
Description: Macrophage inflammatory protein (MIP)-3/CCL20, also known as liver and activation-regulated chemokine (LARC) or Exodus, is a member of the CC chemokine subfamily initially noted to be expressed in human liver, lung, appendix, and tonsillar crypts. MIP-3 is selectively chemotactic for CD34(+) bone marrow cell-derived immature DCs and CD45RO(+) memory T cells that express the cognate receptor CCR6. MIP-3 produced at sites of inflammation may chemoattract CCR6-expressing immature DCs to the subepithelial region of mucosal surfaces. |
Rabbit Anti-human Core-binding factor alpha 3 (CBFA3) aff pure IgG # 1 |
|||
CBFA31-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Recombinant Human Alpha-Synuclein |
|||
RP-847 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Rabbit polyclonal MIP-3 alpha antibody |
|||
TA319360 | Origene Technologies GmbH | 100 µg | Ask for price |
Rabbit polyclonal MIP 3 alpha antibody |
|||
TA319370 | Origene Technologies GmbH | 100 µg | Ask for price |
Alpha 2-Antiplasmin, Human Plasma |
|||
A2AP15-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Expression of ADR-α1, 2 and ADR-β2 in cumulus cellculture of infertile women with polycystic ovary syndrome and poor responder who are a candidate for IVF: the novel strategic role of clonidine in this expression
Objective: Alpha and beta-adrenoceptors (ADR-α1, 2, and β2) play a regulatory role in the folliculogenesis and steroidogenesis in the ovarian follicles. This study aimed to measure these adrenoceptors mRNA and its protein levels in cumulus cells (CCs) culture of poor ovarian reserve (POR) and polycystic ovarian syndrome (PCOS) infertile women (IVF candidate) and the effect of clonidine treatment at CCs culture.
Methods: This case/control study was conducted in 2017 includes a control (donation oocytes) and two studies (PCO and POR) groups. The ovulation induction drugs were prescribed in all groups. After the oocyte puncture, the follicular fluid was collected and CCs were isolated were cultured. RNA was extracted and cDNA was synthesized and designed the primer for the ADR-α1, 2 and ADR-β2 gene expression. The protein levels were investigated by Western Blot.
Results: The results showed a high level of three adrenergic expressions in PCO women compared to the control group (p-value <.001), which can be reduced by clonidine. POR group showed a significant decrease in the gene expression of ADR-α1 (p-value = .004) and ADR-α2 (p-value = .003) compared to the control group and clonidine treatment had no effect.
Conclusion: The significant increase of three adrenoceptors gene expression and protein levels in CCs culture indicate to the hyperactivity of the ovarian sympathetic nervous system at the receptor levels in women with PCOS, and clonidine confirmed it by reducing this expression. In POR women, the reduction of ADR-α1, 2 expressions maybe lead to the aging process in the ovary.
VEGF 121, CF |
|||
PR15029CF | Neuromics | 5 ug | EUR 498 |
VEGF-121-Fc |
|||
E13-m005-1 | EnoGene | 10μg | EUR 225 |
Description: N/A |
VEGF-121-Fc |
|||
E13-m005-2 | EnoGene | 50μg | EUR 1125 |
Description: N/A |
VEGF-121 (His tag) |
|||
EGPS002 | EnoGene | 10ug | EUR 175 |
Human VEGF 121 Antibody |
|||
32562-05111 | AssayPro | 150 ug | EUR 215 |
VEGF 121 Recombinant Protein |
|||
96-768 | ProSci | 0.02 mg | EUR 519 |
Description: Vascular endothelial growth factor (VEGF) is also known as vascular permeability factor (VPF) and VEGF-A, and is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. Alternatively spliced isoforms of 121,145,165,183,189 and 206 amino acids in length are expressed in humans. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189. VEGF121 is the only form that lacks a basic heparinbinding region and is freely diffusible. Mouse embryos expressing only the corresponding isoform (VEGF120) do not survive to term, and show defects in skeletogenesis. Human VEGF121 shares 87% aa sequence identity with corresponding regions of mouse and rat, 93% with feline, equine and bovine, and 91%, 95% and 96% with ovine, canine and porcine VEGF, respectively. VEGF121 induces the proliferation of lymphatic endothelial cells. The lymphangiogenesis may be promoted by upregulation of VEGF121, which may in turn act in part via induction of VEGF-C. |
rHu EG-VEGF |
|||
AK8315-0005 | Akron Biotech | 5µg | Ask for price |
rHu EG-VEGF |
|||
AK8315-0020 | Akron Biotech | 20µg | Ask for price |
rHu EG-VEGF |
|||
AK8315-0100 | Akron Biotech | 100µg | Ask for price |
rHu EG-VEGF |
|||
AK8315-1000 | Akron Biotech | 1mg | Ask for price |
Recombinant Human VEGF 121 Protein |
|||
E40KMP1027 | EnoGene | 20ug | EUR 495 |
Recombinant human VEGF 121 Protein |
|||
MBS9144069-0005mg | MyBiosource | 0.005mg | EUR 145 |
Recombinant human VEGF 121 Protein |
|||
MBS9144069-002mg | MyBiosource | 0.02mg | EUR 195 |
Recombinant human VEGF 121 Protein |
|||
MBS9144069-005mg | MyBiosource | 0.05mg | EUR 255 |
Recombinant human VEGF 121 Protein |
|||
MBS9144069-01mg | MyBiosource | 0.1mg | EUR 335 |
Recombinant human VEGF 121 Protein |
|||
MBS9144069-5x01mg | MyBiosource | 5x0.1mg | EUR 1330 |
OPSD00063-2UG - Recombinant VEGF-121 |
|||
OPSD00063-2UG | Aviva Systems Biology | 2ug | EUR 108 |
Recombinant Human VEGF165 (rHu VEGF165) |
|||
70505 | SAB | 10ul | EUR 235 |
Description: Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using human umbilical vein endothelial cells(HUVEC) is between 1.0-8.0 ng/ml. |
Recombinant Human VEGF165 (rHu VEGF165) |
|||
MBS9419932-001mL | MyBiosource | 0.01mL | EUR 280 |
Recombinant Human VEGF165 (rHu VEGF165) |
|||
MBS9419932-5x001mL | MyBiosource | 5x0.01mL | EUR 1120 |
Vascular Endothelial Growth Factor-121, Recombinant, Human (VEGF-121) |
|||
MBS650732-0002mg | MyBiosource | 0.002mg | EUR 375 |
Vascular Endothelial Growth Factor-121, Recombinant, Human (VEGF-121) |
|||
MBS650732-001mg | MyBiosource | 0.01mg | EUR 455 |
Vascular Endothelial Growth Factor-121, Recombinant, Human (VEGF-121) |
|||
MBS650732-5x001mg | MyBiosource | 5x0.01mg | EUR 1890 |
Vascular Endothelial Growth Factor-121, Recombinant, Human (VEGF-121) |
|||
MBS650596-0002mg | MyBiosource | 0.002mg | EUR 340 |
Vascular Endothelial Growth Factor-121, Recombinant, Human (VEGF-121) |
|||
MBS650596-001mg | MyBiosource | 0.01mg | EUR 490 |
Vascular Endothelial Growth Factor-121, Recombinant, Human (VEGF-121) |
|||
MBS650596-5x001mg | MyBiosource | 5x0.01mg | EUR 2055 |
Human CellExp? VEGF 121, Human Recombinant |
|||
6484-10 | Biovision | each | EUR 411.6 |
Human CellExp? VEGF 121, Human Recombinant |
|||
6484-50 | Biovision | each | EUR 1599.6 |
Human VEGF 121 Antibody (Biotin Conjugate) |
|||
32562-05121 | AssayPro | 150 ug | EUR 315 |
Recombinant human VEGF 121 Protein, His Tag |
|||
E40KMP1359 | EnoGene | 20ug | EUR 495 |
VEGF 121 Recombinant Protein Tag free Lyophilized |
|||
IVEGF121RLY20UG | Innovative research | each | EUR 592 |
Description: VEGF 121 Recombinant Protein Tag free Lyophilized |
VEGF 121 Recombinant Protein Tag free Lyophilized |
|||
MBS8434669-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Vascular Endothelial Growth Factor-121, aa207-327, Recombinant, Human (VEGF-121) |
|||
MBS636283-001mg | MyBiosource | 0.01mg | EUR 750 |
Vascular Endothelial Growth Factor-121, aa207-327, Recombinant, Human (VEGF-121) |
|||
MBS636283-5x001mg | MyBiosource | 5x0.01mg | EUR 3235 |
Vascular Endothelial Growth Factor-121, Recombinant, Human, aa207-327 (VEGF-121) |
|||
MBS650154-005mg | MyBiosource | 0.05mg | EUR 610 |
Vascular Endothelial Growth Factor-121, Recombinant, Human, aa207-327 (VEGF-121) |
|||
MBS650154-5x005mg | MyBiosource | 5x0.05mg | EUR 2600 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (AP) |
|||
MBS6505503-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (AP) |
|||
MBS6505503-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (PE) |
|||
MBS6505512-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (PE) |
|||
MBS6505512-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (AP) |
|||
MBS6505513-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (AP) |
|||
MBS6505513-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (PE) |
|||
MBS6505523-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (PE) |
|||
MBS6505523-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor, Human (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) |
|||
MBS634869-005mg | MyBiosource | 0.05mg | EUR 415 |
Vascular Endothelial Growth Factor, Human (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) |
|||
MBS634869-5x005mg | MyBiosource | 5x0.05mg | EUR 1725 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (APC) |
|||
MBS6505504-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (APC) |
|||
MBS6505504-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (FITC) |
|||
MBS6505505-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (FITC) |
|||
MBS6505505-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (HRP) |
|||
MBS6505506-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (HRP) |
|||
MBS6505506-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (APC) |
|||
MBS6505514-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (APC) |
|||
MBS6505514-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (Biotin) |
|||
MBS6505515-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (Biotin) |
|||
MBS6505515-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (FITC) |
|||
MBS6505516-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (FITC) |
|||
MBS6505516-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (HRP) |
|||
MBS6505517-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (HRP) |
|||
MBS6505517-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Recombinant Human VEGF121 Protein |
|||
PROTP15692-10 | BosterBio | 10ug | EUR 380.4 |
Description: VEGF is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, VEGF plays a prominent role in normal and pathological angiogenesis. VEGF signals through three receptors; fms-like tyrosine kinase (flt-1), KDR gene product (the murine homolog of KDR is the flk-1 gene product) and the flt4 gene product. Due to its increased acidity, VEGF121 circulates more freely than other VEGF forms, which bind more tightly with vascular heparin sulfates. Recombinant human VEGF121 is a 28.4 kDa disulfide-linked homodimeric protein consisting of two 121 amino acid polypeptide chains. |
Human VEGF 121 AssayLite™ Antibody (RPE Conjugate) |
|||
32562-05151 | AssayPro | 150 ug | EUR 370 |
Human VEGF 121 AssayLite™ Antibody (APC Conjugate) |
|||
32562-05161 | AssayPro | 150 ug | EUR 370 |
Human VEGF 121 AssayLite™ Antibody (FITC Conjugate) |
|||
32562-05141 | AssayPro | 150 ug | EUR 370 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 405) |
|||
MBS6505507-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 405) |
|||
MBS6505507-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 490) |
|||
MBS6505508-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 490) |
|||
MBS6505508-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 550) |
|||
MBS6505509-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 550) |
|||
MBS6505509-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 650) |
|||
MBS6505510-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 650) |
|||
MBS6505510-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 750) |
|||
MBS6505511-01mL | MyBiosource | 0.1mL | EUR 1035 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 750) |
|||
MBS6505511-5x01mL | MyBiosource | 5x0.1mL | EUR 4515 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 405) |
|||
MBS6505518-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 405) |
|||
MBS6505518-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 490) |
|||
MBS6505519-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 490) |
|||
MBS6505519-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 550) |
|||
MBS6505520-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 550) |
|||
MBS6505520-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 650) |
|||
MBS6505521-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 650) |
|||
MBS6505521-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 750) |
|||
MBS6505522-01mL | MyBiosource | 0.1mL | EUR 1115 |
Vascular Endothelial Growth Factor (VEGF, VEGF 121, VEGF121, VEGF A, VEGFA, VEGF-A, MGC70609, Vascular Permeability Factor, VPF) (MaxLight 750) |
|||
MBS6505522-5x01mL | MyBiosource | 5x0.1mL | EUR 4875 |
Human VEGF 121 AssayLite™ Antibody (PerCP Conjugate) |
|||
32562-05171 | AssayPro | 150 ug | EUR 410 |
VEGF (121 a.a.), Vascular Endothelial Growth Factor-121 Human Recombinant Protein, His Tag |
|||
PROTP15692-8 | BosterBio | Regular: 10ug | EUR 380.4 |
Description: Vascular Endothelial Growth Factor-121 Human Recombinant produced in E.Coli is a double, non-glycosylated, polypeptide chain (aa 207-327) containing a total of 142 amino acids and having a molecular mass of 16.3 kDa. ;The VEGF-121 is fused to a 20 amino acid His tag at N-terminus and purified by proprietary chromatographic techniques. |
Vascular Endothelial Growth Factor-121, aa207-327, Recombinant, Human (VEGF-121) (BSA Free) |
|||
MBS635981-001mg | MyBiosource | 0.01mg | EUR 750 |